Back
MEI Pharma Vs. Revance Therapeutics Industry Stock Comparison
Buy
61
MEIP
MEI Pharma
Last Price:
3.00
Seasonality Move:
4.15%
Sell
17
RVNC
Revance Therapeutics
Last Price:
4.32
Seasonality Move:
7.02%
Buy
61
MEI Pharma (MEIP)
is a Buy
Is MEI Pharma a Buy, Sell or Hold?
- The current MEI Pharma [MEIP] share price is $3.01. The Score for MEIP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- MEIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $4.31. The Score for RVNC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MEIP Stock Price Chart
What is MEI Pharma's stock price today?
-
The MEI Pharma share price today is $3.01
The current trend is moderately bullish and MEIP is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $4.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.
MEIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 52.84 | Buy |
Chaikin Money Flow: | -6194 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.75 - 3.09) | Buy |
Bollinger Bands (100): | (2.79 - 3.29) | Sell |
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 38.37 | Sell |
Chaikin Money Flow: | 647205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.49 - 5.89) | Sell |
Bollinger Bands (100): | (3.57 - 6.31) | Sell |
MEIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.06 | Sell |
20-day SMA: | 2.98 | Buy |
50-day SMA: | 2.93 | Buy |
200-day SMA: | 3.31 | Sell |
8-day EMA: | 3.05 | Sell |
20-day EMA: | 3 | Buy |
50-day EMA: | 2.98 | Buy |
200-day EMA: | 3.62 | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.66 | Sell |
20-day SMA: | 5.18 | Sell |
50-day SMA: | 5.48 | Sell |
200-day SMA: | 4.64 | Sell |
8-day EMA: | 4.55 | Sell |
20-day EMA: | 4.98 | Sell |
50-day EMA: | 5.21 | Sell |
200-day EMA: | 6.14 | Sell |
MEI Pharma Earnings Growth & MEIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
MEI Pharma Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Revance Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |